KW
Kirti Wardhaman Ganorkar
About Kirti Wardhaman Ganorkar
Data last updated:
Kirti Wardhaman Ganorkar is a Managing Director at Sun Pharmaceutical Industries Limited (since 2025), Director at Sun Pharma Distributors Limited (since 2024) and Whole-Time Director at Sun Pharma Laboratories Limited (since 2024). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹90,036 Cr; the largest is Sun Pharmaceutical Industries Limited at ₹60,434 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Pharmaceutical Industries Limited L24230GJ1993PLC019050 | Managing Director | 01 Sep 2025 | 1993 | ₹60,434 Cr (FY 2026) | Active |
 Sun Pharma Distributors Limited U51909MH2019PLC322778 | Director | 07 May 2024 | 2019 | ₹16,887 Cr (FY 2025) | Active |
 Sun Pharma Laboratories Limited U25200GJ1997PLC133846 | Whole-Time Director | 21 May 2024 | 1997 | ₹12,715 Cr (FY 2024) | Active |
Board colleagues of Kirti Wardhaman Ganorkar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kirti Wardhaman Ganorkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kirti Wardhaman Ganorkar
Kirti Wardhaman Ganorkar currently holds 3 directorships: Sun Pharmaceutical Industries Limited (Managing Director, since 01 Sep 2025, revenue ₹60,434 Cr (FY 2026)); Sun Pharma Distributors Limited (Director, since 07 May 2024, revenue ₹16,887 Cr (FY 2025)); Sun Pharma Laboratories Limited (Whole-Time Director, since 21 May 2024, revenue ₹12,715 Cr (FY 2024)).
Kirti Wardhaman Ganorkar was first appointed on 07 May 2024 as Director at Sun Pharma Distributors Limited. The most recent appointment on record is 01 Sep 2025 at Sun Pharmaceutical Industries Limited.
The 3 current companies of Kirti Wardhaman Ganorkar that report revenue have a combined latest revenue of ₹90,036 Cr: Sun Pharmaceutical Industries Limited ₹60,434 Cr (FY 2026); Sun Pharma Distributors Limited ₹16,887 Cr (FY 2025); Sun Pharma Laboratories Limited ₹12,715 Cr (FY 2024).
The current boards of Kirti Wardhaman Ganorkar's companies include Aalok Dilip Shanghvi (Sun Pharmaceutical Industries Limited), Andreas Eugen Busch (Sun Pharmaceutical Industries Limited), Anoop Anjanikumar Deshpande (Sun Pharmaceutical Industries Limited), Dilip Shantilal Shanghvi (Sun Pharmaceutical Industries Limited), Gautam Bhailal Doshi (Sun Pharmaceutical Industries Limited), Jayashree Satagopan (Sun Pharmaceutical Industries Limited), among others.